Item Type | Name |
Concept
|
Nervous System Diseases
|
Concept
|
Nerve Block
|
Concept
|
Peripheral Nervous System Diseases
|
Concept
|
Central Nervous System Neoplasms
|
Concept
|
Hemangioma, Cavernous, Central Nervous System
|
Concept
|
Phrenic Nerve
|
Concept
|
Spinal Nerve Roots
|
Concept
|
Central Nervous System Vascular Malformations
|
Academic Article
|
Ultrastructural pathological features of cerebrovascular malformations: a preliminary report.
|
Academic Article
|
Multiple spinal cavernous malformations with atypical phenotype after prior irradiation: case report.
|
Academic Article
|
Biallelic somatic and germ line CCM1 truncating mutations in a cerebral cavernous malformation lesion.
|
Academic Article
|
Delayed facial nerve palsy after temporal lobectomy for epilepsy: report of four cases and discussion of possible mechanisms.
|
Academic Article
|
Intracranial dural arteriovenous malformations: factors predisposing to an aggressive neurological course.
|
Academic Article
|
Neurological deterioration in a patient with a spinal arteriovenous malformation following lumbar puncture. Case report.
|
Academic Article
|
Spectrum of genotype and clinical manifestations in cerebral cavernous malformations.
|
Academic Article
|
Advanced magnetic resonance imaging of cerebral cavernous malformations: part II. Imaging of lesions in murine models.
|
Academic Article
|
Oligoclonal immune response in cerebral cavernous malformations. Laboratory investigation.
|
Academic Article
|
Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity.
|
Academic Article
|
A novel mouse model of cerebral cavernous malformations based on the two-hit mutation hypothesis recapitulates the human disease.
|
Academic Article
|
A founder mutation in the Ashkenazi Jewish population affecting messenger RNA splicing of the CCM2 gene causes cerebral cavernous malformations.
|
Academic Article
|
Cavernous malformations.
|
Academic Article
|
Fatal "hypertensive" intracerebral hemorrhage associated with a cerebral cavernous angioma: case report.
|
Academic Article
|
Magnetic resonance imaging evaluation of cerebral cavernous malformations with susceptibility-weighted imaging.
|
Academic Article
|
Cerebral cavernous malformations: clinical insights from genetic studies.
|
Academic Article
|
Different spectra of genomic deletions within the CCM genes between Italian and American CCM patient cohorts.
|
Academic Article
|
Galen's anecdote of the fallen sophist: on the certainty of science through anatomy.
|
Academic Article
|
Brainstem cavernous malformations.
|
Academic Article
|
Cerebral cavernous malformations as a disease of vascular permeability: from bench to bedside with caution.
|
Academic Article
|
Expression of angiogenic factors and structural proteins in central nervous system vascular malformations.
|
Academic Article
|
Advanced magnetic resonance imaging of cerebral cavernous malformations: part I. High-field imaging of excised human lesions.
|
Academic Article
|
Immune response in human cerebral cavernous malformations.
|
Academic Article
|
Biology of vascular malformations of the brain.
|
Academic Article
|
Application of magnetic resonance angiography to neurosurgical practice: a critical review of 150 cases.
|
Academic Article
|
Perioperative management and outcome after surgical treatment of anterior cerebral artery aneurysms.
|
Academic Article
|
Sclerosing vasculopathy of the central nervous system in nonelderly demented patients.
|
Academic Article
|
Neurologic surgery.
|
Academic Article
|
Intracranial cavernous angioma: a practical review of clinical and biological aspects.
|
Academic Article
|
Cerebral cavernous malformations and epilepsy.
|
Academic Article
|
Radiosurgery for angiographically occult vascular malformations.
|
Academic Article
|
Emerging clinical imaging techniques for cerebral cavernous malformations: a systematic review.
|
Academic Article
|
What genes can teach us about human cerebrovascular malformations.
|
Academic Article
|
Effect of local anaesthetic volume (20 vs 5 ml) on the efficacy and respiratory consequences of ultrasound-guided interscalene brachial plexus block.
|
Academic Article
|
Management of incidental cavernous malformations: a review.
|
Academic Article
|
Evaluation of iron content in human cerebral cavernous malformation using quantitative susceptibility mapping.
|
Academic Article
|
Immune complex formation and in situ B-cell clonal expansion in human cerebral cavernous malformations.
|
Academic Article
|
Exceptional aggressiveness of cerebral cavernous malformation disease associated with PDCD10 mutations.
|
Academic Article
|
Dynamic permeability and quantitative susceptibility: related imaging biomarkers in cerebral cavernous malformations.
|
Academic Article
|
Extent of resection in temporal lobectomy for epilepsy. II. Memory changes and neurologic complications.
|
Academic Article
|
Lesions from patients with sporadic cerebral cavernous malformations harbor somatic mutations in the CCM genes: evidence for a common biochemical pathway for CCM pathogenesis.
|
Academic Article
|
Vascular permeability in cerebral cavernous malformations.
|
Academic Article
|
Peripheral plasma vitamin D and non-HDL cholesterol reflect the severity of cerebral cavernous malformation disease.
|
Academic Article
|
Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling.
|
Academic Article
|
B-Cell Depletion Reduces the Maturation of Cerebral Cavernous Malformations in Murine Models.
|
Academic Article
|
Micro-computed tomography in murine models of cerebral cavernous malformations as a paradigm for brain disease.
|
Academic Article
|
RhoA Kinase Inhibition With Fasudil Versus Simvastatin in Murine Models of Cerebral Cavernous Malformations.
|
Academic Article
|
Vascular permeability and iron deposition biomarkers in longitudinal follow-up of cerebral cavernous malformations.
|
Academic Article
|
Endothelial TLR4 and the microbiome drive cerebral cavernous malformations.
|
Academic Article
|
The cerebral cavernous malformation disease causing gene KRIT1 participates in intestinal epithelial barrier maintenance and regulation.
|
Academic Article
|
Thrombospondin1 (TSP1) replacement prevents cerebral cavernous malformations.
|
Academic Article
|
Quantitative susceptibility mapping as a monitoring biomarker in cerebral cavernous malformations with recent hemorrhage.
|
Academic Article
|
Patients with cranial dural arteriovenous fistulas may benefit from expanded hypercoagulability and cancer screening.
|
Academic Article
|
Cerebral cavernous malformations form an anticoagulant vascular domain in humans and mice.
|
Academic Article
|
Trial Readiness in Cavernous Angiomas With Symptomatic Hemorrhage (CASH).
|
Academic Article
|
Plasma Biomarkers of Inflammation Reflect Seizures and Hemorrhagic Activity of Cerebral Cavernous Malformations.
|
Academic Article
|
Atorvastatin Treatment of Cavernous Angiomas with Symptomatic Hemorrhage Exploratory Proof of Concept (AT CASH EPOC) Trial.
|
Academic Article
|
Plasma Biomarkers of Inflammation and Angiogenesis Predict Cerebral Cavernous Malformation Symptomatic Hemorrhage or Lesional Growth.
|
Academic Article
|
Rho Kinase Inhibition Blunts Lesion Development and Hemorrhage in Murine Models of Aggressive Pdcd10/Ccm3 Disease.
|
Academic Article
|
A conserved CCM complex promotes apoptosis non-autonomously by regulating zinc homeostasis.
|
Academic Article
|
Transcriptome clarifies mechanisms of lesion genesis versus progression in models of Ccm3 cerebral cavernous malformations.
|
Academic Article
|
Distinct cellular roles for PDCD10 define a gut-brain axis in cerebral cavernous malformation.
|
Academic Article
|
Cerebral Cavernous Malformation Proteins in Barrier Maintenance and Regulation.
|
Academic Article
|
Stereotactic laser interstitial thermal therapy for epilepsy associated with solitary and multiple cerebral cavernous malformations.
|
Academic Article
|
Subclinical imaging changes in cerebral cavernous angiomas during prospective surveillance.
|
Academic Article
|
Antibodies in cerebral cavernous malformations react with cytoskeleton autoantigens in the lesional milieu.
|
Academic Article
|
Common transcriptome, plasma molecules, and imaging signatures in the aging brain and a Mendelian neurovascular disease, cerebral cavernous malformation.
|
Academic Article
|
Cerebral cavernous malformations are driven by ADAMTS5 proteolysis of versican.
|
Academic Article
|
Propranolol inhibits cavernous vascular malformations by ß1 adrenergic receptor antagonism in animal models.
|
Academic Article
|
A Roadmap for Developing Plasma Diagnostic and Prognostic Biomarkers of Cerebral Cavernous Angioma With Symptomatic Hemorrhage (CASH).
|
Academic Article
|
PIK3CA and CCM mutations fuel cavernomas through a cancer-like mechanism.
|
Academic Article
|
Abortive intussusceptive angiogenesis causes multi-cavernous vascular malformations.
|
Academic Article
|
Astrocytes propel neurovascular dysfunction during cerebral cavernous malformation lesion formation.
|
Academic Article
|
Cerebral Cavernous Malformation: From Mechanism to Therapy.
|
Academic Article
|
Commentary: Feasibility and Morbidity of Magnetic Resonance Imaging-Guided Stereotactic Laser Ablation of Deep Cerebral Cavernous Malformations: A Report of 4 Cases.
|
Academic Article
|
COVID-19 in a Hemorrhagic Neurovascular Disease, Cerebral Cavernous Malformation.
|
Academic Article
|
Baseline Characteristics of Patients With Cavernous Angiomas With Symptomatic Hemorrhage in Multisite Trial Readiness Project.
|
Academic Article
|
Propranolol as therapy for cerebral cavernous malformations: a cautionary note.
|
Academic Article
|
Circulating Plasma miRNA Homologs in Mice and Humans Reflect Familial Cerebral Cavernous Malformation Disease.
|
Academic Article
|
Multidisciplinary coordinated care of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease).
|
Academic Article
|
Impact of socioeconomics and race on clinical follow-up and trial enrollment and adherence in cerebral cavernous malformation.
|
Academic Article
|
Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part II: Biomarkers and Trial Modeling.
|
Academic Article
|
Trial Readiness of Cavernous Malformations With Symptomatic Hemorrhage, Part I: Event Rates and Clinical Outcome.
|
Academic Article
|
Transcriptomic signatures of individual cell types in cerebral cavernous malformation.
|
Academic Article
|
Antithrombotic Therapy in Cerebral Cavernous Malformations: A Systematic Review, Meta-Analysis, and Network Meta-Analysis.
|